SCHEMBL709407

SCHEMBL709407

CCOC(CC(CO)CO)OCC

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.38
LMNA P02545 2/20 0.36
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13767995 0.87 THRB (0.33) THRBLMNAALDH1A1
SCHEMBL14595246 0.87
SCHEMBL712328 0.80 ALDH1A1 (0.40) LMNAALDH1A1
SCHEMBL605278 0.79
SCHEMBL29244100 0.79 THRB (0.35) THRBLMNAALDH1A1
SCHEMBL46524 0.78 THRB (0.50) THRBLMNA
SCHEMBL27698012 0.77 THRB (0.42) THRBLMNAALDH1A1
SCHEMBL27608092 0.77 THRB (0.42) THRBLMNAALDH1A1
Alcohol SCHEMBL7259757 0.77 THRB (0.42) THRBLMNAALDH1A1
SCHEMBL15880022 0.76 THRB (0.36) THRBLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115850673-A Preparation method of low molecular weight poly (gamma-butyrolactone) polyalcohol 青岛科技大学 2023-03-28 CN claimed
CN-115850673-B Preparation method of low molecular weight poly (gamma-butyrolactone) polyol 青岛科技大学 2024-06-18 CN disclosed
US-11959115-B2 Saccharification reaction mixture, saccharification enzyme composition, sugar production method, and ethanol production method NISSAN CHEMICAL CORPORATION (JP) 2024-04-16 US disclosed
US-20230210808-A1 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS CYMABAY THERAPEUTICS, INC. 2023-07-06 US disclosed
CN-115850673-A Preparation method of low molecular weight poly (gamma-butyrolactone) polyalcohol 青岛科技大学 2023-03-28 CN disclosed
US-20220267819-A1 SACCHARIFICATION REACTION MIXTURE, SACCHARIFICATION ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD NISSAN CHEMICAL CORPORATION (JP) 2022-08-25 US disclosed
US-11359220-B2 Saccharification reaction mixture, saccharification enzyme composition, sugar production method, and ethanol production method NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2022-06-14 US disclosed
CN-108463562-B Saccharification reaction liquid, saccharifying enzyme composition, method for producing sugar, and method for producing ethanol 日产化学工业株式会社 2022-05-03 CN disclosed
EP-3372697-B1 SACCHARIFICATION REACTION LIQUID, SACCHARIFICATION ENZYME COMPOSITION, PRODUCTION METHOD FOR SUGAR, AND PRODUCTION METHOD FOR ETHANOL NISSAN CHEMICAL CORP (JP) 2021-09-15 EP disclosed
US-20180298412-A1 SACCHARIFICATION REACTION MIXTURE, SACCHARIFICATION ENZYME COMPOSITION, SUGAR PRODUCTION METHOD, AND ETHANOL PRODUCTION METHOD NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-10-18 US disclosed
US-5869493-A ANTIVIRALS AGAINST HERPES AND RETROVIRUSES MEDIVIR AB (SE) 1999-02-09 US disclosed
EP-0888348-A1 ACYCLIC NUCLEOSIDE DERIVATIVES Medivir Aktiebolag (SE) 1999-01-07 EP disclosed
EP-0880521-A1 SYNTHESIS OF ACYCLIC NUCLEOSIDES Medivir Aktiebolag (SE) 1998-12-02 EP disclosed
WO-1998034917-A2 SYNTHESIS OF ACYCLIC NUCLEOSIDE DERIVATIVES MEDIVIR AB (SE) 1998-08-13 WO disclosed
WO-1997030051-A1 ACYCLIC NUCLEOSIDE DERIVATIVES MEDIVIR AB (SE) 1997-08-21 WO disclosed
WO-1997030052-A1 SYNTHESIS OF ACYCLIC NUCLEOSIDES MEDIVIR AB (SE) 1997-08-21 WO disclosed
EP-0573455-A1 METHOD OF PREPARATION OF PILOCARPINES AND INTERMEDIATES THEREOF MACFARLAN SMITH LIMITED (GB) 1993-12-15 EP disclosed
WO-1992014693-A1 METHOD OF PREPARATION OF PILOCARPINES AND INTERMEDIATES THEREOF MACFARLAN SMITH LIMITED (GB) 1992-09-03 WO disclosed
US-4980362-A PLATELET ACTIVATING FACTOR ANTAGONISTS J. URIACH & CIA. S.A. (ES) 1990-12-25 US disclosed
EP-0381098-A2 New 4-substituted 2-alkoxytetrahydrofuran derivatives J. URIACH & CIA. S.A. (ES) 1990-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230210808-A1 4-(PHENOXYALKYL)THIO)-PHENOXYACETIC ACIDS AND ANALOGS PPARA, PPARG, PPARD THRB 66/4885LMNA 2274/4885ALDH1A1 1562/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.